Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Gand

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of the American Heart Association|February 27, 2018
Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes MellitusMaxime Cournot, Elena Burillo, Pierre-Jean Saulnier, et al.
Diabetes, Obesity & Metabolism|November 3, 2016
Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetesStéphanie Laugier-Robiolle, Bruno Vergès, Maëlle Le Bras, et al.
Diabetologia|February 11, 2020
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohortBarnabas Gellen, Nathalie Thorin-Trescases, Eric Thorin, et al.
Diabetes Care|October 15, 2020
Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 DiabetesNinon Foussard, Pierre-Jean Saulnier, Louis Potier, et al.
Diabetes|May 8, 2015
Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Kidney Disease in People With Type 2 DiabetesGilberto Velho, Stéphanie Ragot, Kamel Mohammedi, et al.
Diabetes Care|March 14, 2014
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE CohortPierre-Jean Saulnier, Elise Gand, Stéphanie Ragot, et al.
Diabetes Care|May 26, 2016
Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 DiabetesStéphanie Ragot, Pierre-Jean Saulnier, Gilberto Velho, et al.
Diabetologia|September 21, 2018
Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective studyMathilde Fraty, Gilberto Velho, Elise Gand, et al.
Diabetes Care|August 4, 2018
Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 DiabetesMathilde Nativel, Fabrice Schneider, Pierre-Jean Saulnier, et al.
Diabetologia|January 7, 2021
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE studyCapucine Bertrand, Pierre-Jean Saulnier, Louis Potier, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of the American Heart Association|February 27, 2018
Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes MellitusMaxime Cournot, Elena Burillo, Pierre-Jean Saulnier, et al.
Diabetes, Obesity & Metabolism|November 3, 2016
Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetesStéphanie Laugier-Robiolle, Bruno Vergès, Maëlle Le Bras, et al.
Diabetologia|February 11, 2020
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohortBarnabas Gellen, Nathalie Thorin-Trescases, Eric Thorin, et al.
Diabetes Care|October 15, 2020
Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 DiabetesNinon Foussard, Pierre-Jean Saulnier, Louis Potier, et al.
Diabetes|May 8, 2015
Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Kidney Disease in People With Type 2 DiabetesGilberto Velho, Stéphanie Ragot, Kamel Mohammedi, et al.
Diabetes Care|March 14, 2014
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE CohortPierre-Jean Saulnier, Elise Gand, Stéphanie Ragot, et al.
Diabetes Care|May 26, 2016
Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 DiabetesStéphanie Ragot, Pierre-Jean Saulnier, Gilberto Velho, et al.
Diabetologia|September 21, 2018
Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective studyMathilde Fraty, Gilberto Velho, Elise Gand, et al.
Diabetes Care|August 4, 2018
Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 DiabetesMathilde Nativel, Fabrice Schneider, Pierre-Jean Saulnier, et al.
Diabetologia|January 7, 2021
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE studyCapucine Bertrand, Pierre-Jean Saulnier, Louis Potier, et al.
Pageof 4